{
    "clinical_study": {
        "@rank": "117604", 
        "acronym": "USF", 
        "arm_group": {
            "arm_group_label": "ablathermy focused ultrasound", 
            "arm_group_type": "Experimental", 
            "description": "ablathermy focused ultrasound"
        }, 
        "brief_summary": {
            "textblock": "The treatment consists of tumor ablation by Ablathermy Focused Ultrasound  (USF), guided by\n      MRI, performed under local anesthesia and sedation."
        }, 
        "brief_title": "Feasibility Study of Ablathermy Focused Ultrasound (USF) of Breast Tumors Before Mastectomy", 
        "completion_date": {
            "#text": "March 2011", 
            "@type": "Actual"
        }, 
        "condition": "Breast Tumor", 
        "condition_browse": {
            "mesh_term": "Breast Neoplasms"
        }, 
        "detailed_description": {
            "textblock": "The treatment consists of tumor ablation by USF, guided by MRI, performed under local\n      anesthesia and sedation. Patients will be operated (mastectomy) from 48 hours after\n      ablation."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Invasive Breast Carcinoma with histologically confirmed hormone receptor analysis,\n             the grade of the tumor, the expression of Her-2.\n\n          -  Lesion classified T1-T2-T3 unifocal or multifocal with or without associated\n             microcalcifications\n\n          -  Lesion recognizable and identifiable in MRI\n\n          -  Indication of mastectomy with or without axillary\n\n          -  Lesion located more than 10 mm from the skin, the nipple and pectoralis major\n\n          -  No cons-indication to MRI (pacemaker)\n\n          -  Women whose age is \u2265 18 years\n\n          -  If premenopausal patient: patient contraceptives\n\n          -  Patient has signed informed consent\n\n          -  Affiliation to a social security scheme\n\n        Exclusion Criteria:\n\n          -  Tumor-TD T4B classified or non-palpable lesion\n\n          -  If age <70 years: no indication of adjuvant chemotherapy and neoadjuvant\n\n          -  MRI lesions have not been identified, located within 10 mm of the skin and pectoral\n             muscle, greater than 25 mm diameter\n\n          -  Inability to hold still in the prone position, arms extended, for 30 minutes\n\n          -  Contraindication to MRI\n\n          -  Patient deprived of liberty and major subject of a measure of legal protection or\n             unable to consent\n\n          -  Patient participating in another interventional clinical trial within 30 days prior\n             to baseline and during the trial."
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "1", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "November 6, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01827969", 
            "org_study_id": "IB2009-58"
        }, 
        "intervention": {
            "arm_group_label": "ablathermy focused ultrasound", 
            "description": "ablathermy focused ultrasound", 
            "intervention_name": "ablathermy focused ultrasound", 
            "intervention_type": "Procedure"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Women", 
            "breast tumor", 
            "planned mastectomy"
        ], 
        "lastchanged_date": "April 9, 2013", 
        "link": {
            "description": "Site internet du promoteur, l'Institut Bergoni\u00e9", 
            "url": "http://www.bergonie.org/fr/essais-clinique.html"
        }, 
        "location": {
            "facility": {
                "address": {
                    "city": "Bordeaux", 
                    "country": "France", 
                    "state": "Aquitaine", 
                    "zip": "33000"
                }, 
                "name": "Institut Bergoni\u00e9"
            }
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "1", 
        "official_title": "Feasibility Study of Ablathermy Focused Ultrasound (USF) of Breast Tumors Before Mastectomy", 
        "overall_official": {
            "affiliation": "Institut Bergoni\u00e9", 
            "last_name": "PALUSSIERE Jean, MD", 
            "role": "Study Chair"
        }, 
        "overall_status": "Terminated", 
        "oversight_info": {
            "authority": "France: Afssaps - Agence fran\u00e7aise de s\u00e9curit\u00e9 sanitaire des produits de sant\u00e9 (Saint-Denis)", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2011", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Evaluate the effectiveness of ablathermy focused ultrasound breast tumors on histological criteria in terms of destruction of the tumor mass by coagulation necrosis", 
            "measure": "Evaluate the effectiveness of ablathermy", 
            "safety_issue": "No", 
            "time_frame": "2 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01827969"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Assessment of apoptotic phenomena in the margins of lesions treated\nKnow the immediate complications focused ultrasound\nAssess the pain experienced by patients during the procedure performed under sedation.\nCheck the real-time processing by mapping temperature measured by MRI and correlate these mappings to the histological findings", 
            "measure": "- Assessment of apoptotic phenomena in the margins of lesions treated", 
            "safety_issue": "No", 
            "time_frame": "2 years"
        }, 
        "source": "Institut Bergoni\u00e9", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Institut Bergoni\u00e9", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2009", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Open Label", 
        "study_type": "Interventional", 
        "verification_date": "April 2013", 
        "why_stopped": "Recruitment difficulties"
    }
}